Yüklüyor......
The Challenges of Checkpoint Inhibition in the Treatment of Multiple Myeloma
Despite significant improvements in the overall survival of patients with multiple myeloma (MM) over the past 15 years, the disease remains incurable. Treatment options are limited for patients who have relapsed or are refractory to immunomodulatory drugs (IMiDs), proteasome inhibitors, and monoclon...
Kaydedildi:
| Yayımlandı: | Cell Immunol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309858/ https://ncbi.nlm.nih.gov/pubmed/30342750 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cellimm.2018.10.003 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|